EDAP to Present at the Jefferies Global Healthcare Conference
EDAP TMS SA, a leader in robotic energy-based therapies, announced that CEO Ryan Rhodes will present and host investor meetings at the Jefferies Global Healthcare Conference on June 5-6, 2024, in New York City. The presentation is scheduled for June 5th at 7:30 AM ET. A live and archived webcast will be accessible on the company's website.
- EDAP's CEO presenting at a major healthcare conference increases visibility and investor interest.
- Participation in the Jefferies Global Healthcare Conference highlights EDAP's industry relevance.
- Hosting 1x1 investor meetings can build stronger investor relations and potentially attract new investments.
- There are no immediate revenue or profit updates provided in the announcement.
- The impact of the presentation on the stock price is uncertain and may not be significant.
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 5-6, 2024, in New York City.
Presentation details:
| Date: | Wednesday, June 5th |
| Time: | 7:30 AM ET |
| Webcast: | https://wsw.com/webcast/jeff302/edap/1814176 |
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP presenting at the Jefferies Global Healthcare Conference?
Who will represent EDAP at the Jefferies Global Healthcare Conference?
Where can I access the live and archived webcast of EDAP's presentation?
